Castleview Partners, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
Castleview Partners, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$7,843
+0.9%
770.0%0.01%0.0%
Q2 2023$7,770
+9.7%
770.0%0.01%
+16.7%
Q1 2023$7,084
+1.4%
770.0%0.01%
-14.3%
Q4 2022$6,985
-46.3%
77
-56.5%
0.01%
-41.7%
Q3 2022$13,000
-87.3%
177
+26.4%
0.01%
Q2 2022$102,000
+13.3%
140
-86.4%
0.00%
-100.0%
Q1 2022$90,000
+15.4%
1,027
+20.8%
0.06%
+64.7%
Q2 2021$78,0008500.03%
Other shareholders
NOVARTIS A G shareholders Q4 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders